SRC
PFE icon

Sage Rhino Capital’s Pfizer PFE Stock Holding History

Sage Rhino Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,022
Closed -$202K – 244
2023
Q4 		$202K Buy
7,022
+60
+0.9% +$1.81K 0.05% 204
2023
Q3 		$231K Sell
6,962
-696
-9% -$24.6K 0.06% 183
2023
Q2 		$281K Sell
7,658
-651
-8% -$25.3K 0.08% 168
2023
Q1 		$339K Buy
8,309
+361
+5% +$15.6K 0.1% 148
2022
Q4 		$407K Buy
7,948
+119
+2% +$5.71K 0.13% 124
2022
Q3 		$343K Sell
7,829
-309
-4% -$15K 0.14% 116
2022
Q2 		$427K Buy
8,138
+146
+2% +$7.44K 0.16% 104
2022
Q1 		$414K Buy
7,992
+122
+2% +$6.33K 0.13% 138
2021
Q4 		$465K Buy
7,870
+168
+2% +$8.32K 0.13% 129
2021
Q3 		$331K Sell
7,702
-58
-0.7% -$2.57K 0.1% 144
2021
Q2 		$304K Buy
7,760
+204
+3% +$7.93K 0.09% 151
2021
Q1 		$274K Sell
7,556
-11
-0.1% -$391 0.09% 143
2020
Q4 		$279K Sell
7,567
-287
-4% -$10.5K 0.11% 136
2020
Q3 		$273K Sell
7,854
-25
-0.3% -$877 0.13% 123
2020
Q2 		$244K Buy
7,879
+234
+3% +$7.95K 0.13% 127
2020
Q1 		$237K Sell
7,645
-1,943
-20% -$66.2K 0.17% 107
2019
Q4 		$359K Buy
9,588
+742
+8% +$26.4K 0.2% 102
2019
Q3 		$302K Sell
8,846
-756
-8% -$27.5K 0.19% 102
2019
Q2 		$395K Sell
9,602
-135
-1% -$5.36K 0.25% 84
2019
Q1 		$392K Buy
+9,737
New +$390K 0.26% 81

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sage Rhino Capital's PFE Position: Q1 2024 in Review

Sage Rhino Capital sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,022 shares — an estimated $202K sold.

Sage Rhino Capital first reported a position in PFE in Q1 2019 and held it in 20 quarters. The position peaked at $465K in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Sage Rhino Capital reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Sage Rhino Capital sold 7,022 Pfizer shares in Q1 2024, an estimated $202K.
  • Sage Rhino Capital first reported a position in Pfizer in Q1 2019 and held it in 20 quarters.
  • Sage Rhino Capital's Pfizer position peaked at $465K in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Sage Rhino Capital's 13F filing for Q1 2024, filed 26 Apr 2024.